Signe Koggersbøl Skadborg - National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital Herlev

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 28 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Table S6 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg,Simone Maarup,Arianna Draghi,Annie Borch, Sille Hendriksen,Filip Mundt,Vilde Pedersen,Matthias Mann, Ib J. Christensen,Jane Skjøth-Ramussen,Christina W. Yde,Bjarne W. Kristensen,Hans S. Poulsen,Benedikte Hasselbalch,Inge M. Svane,Ulrik Lassen,Sine R. Hadrup

crossref（2024）

Cited0Views0Bibtex

Figure S1 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Dose Escalation Study of a Personalized Peptide-Based Neoantigen Vaccine (EVX-01) in Patients with Metastatic Melanoma

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 5 (2024)

Cited0Views0WOSBibtex

Figure S11 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg,Simone Maarup,Arianna Draghi,Annie Borch, Sille Hendriksen,Filip Mundt,Vilde Pedersen,Matthias Mann,Ib J. Christensen,Jane Skjoth-Ramussen,Christina W. Yde,Bjarne W. Kristensen,Hans S. Poulsen,Benedikte Hasselbalch,Inge M. Svane,Ulrik Lassen,Sine R. Hadrup

CANCER IMMUNOLOGY RESEARCHno. 9 (2024): 1202-1220

Cited0Views0WOSBibtex

Figure S8 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Figure S5 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Figure S7 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Figure S6 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Table S5 from Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn